Mobile website
Archive > Volume 33 Issue 3 > 2026,33(3):270-279. DOI:10.3872/j.issn.1007-385X.2026.03.006 Prev Next
Basic Research
Mechanism study on regulation of the LGALS3/PI3K/AKT signaling pathway by Paris polyphylla saponin Ⅱ in inhibiting the malignant biological behaviors of thyroid cancer cells
- Article
- Figures
- Metrics
- Preview PDF
- Reference
- Related
- Cited by
- Materials
Abstract:
[Abstract] Objective: To investigate the molecular mechanisms by which Paris polyphyllaa saponin (PPⅡ) suppresses the malignant biological behaviors of thyroid cancer (TC). Methods: Thyroid cancer TPC1 cells were routinely cultured and divided into five experimental groups, designated as sh-NC, sh-lectin-galactoside binding-soluble 3 (sh-LGALS3), OE-NC, OE-LGALS3, and OELGALS3 + PPⅡ. TPC1 cells in each group were transfected with corresponding plasmids using transfection reagents.qPCR was used to detect the expression of LGALS3 mRNA in TPC1 cells. WB was performed to examine the expression of LGALS3 and PI3K/AKT signaling pathway-related proteins. CCK-8 assay, Transwell assay, wound healing assay, and flow cytometry were used to assess the proliferation, migration, invasion, and apoptosis of TPC1 cells in each group. Results: PPⅡ significantly inhibited the proliferation, migration, and invasion of TPC1 cells, while inducing apoptosis (all P < 0.000 1). Database analyses revealed that LGALS3 was highly expressed in thyroid cancer tissues (P < 0.001) and was identified as a potential target gene of PPⅡ. LGALS3 was highly expressed in TPC1 cells (P < 0.000 1). Knockdown of LGALS3 suppressed the malignant biological behaviors of TPC1 cells and promoted apoptosis (all P < 0.000 1). PPⅡ inhibited the malignant biological behaviors of TPC1 cells by downregulating LGALS3 mRNA and protein expression (P < 0.01 or P < 0.001). Furthermore, PP Ⅱ suppressed the activation of the PI3K/AKT signaling pathway by inhibiting LGALS3 expression (P < 0.001 or P < 0.000 1). LGALS3 promoted the malignant biological behaviors of TPC1 cells through the PI3K/AKT signaling pathway (P < 0.000 1). Conclusion: PPⅡ exerts anti-tumor effects in thyroid cancer by inhibiting LGALS3 expression in TPC1 cells and attenuating the overactivation of the PI3K/AKT signaling pathway.
Keywords:
Project Supported:
Clc Number:
